Treatment Decision Impact of OncotypeDX™ in HR+, N- Breast Cancer Patients (SWITCH)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01446185
Recruitment Status : Completed
First Posted : October 5, 2011
Last Update Posted : April 18, 2013
Information provided by (Responsible Party):
Genomic Health®, Inc.

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : February 2012
  Actual Study Completion Date : May 2012